We are live on
!
Find out more
KA
Klingman & Associates Portfolio holdings
AUM
$2.09B
1-Year Est. Return
16.49%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+16.49%
3 Year Est. Return
+47.09%
5 Year Est. Return
+51.57%
10 Year Est. Return
+158.57%
AUM
$1.04B
AUM Growth
+$75.5M
(+7.8%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
56.76%
Holding
181
New
9
Increased
59
Reduced
50
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.58M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$3.37M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.22M |
| 4 |
Dimensional US Targeted Value ETF
DFAT
|
+$2.92M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$2.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$5.39M |
| 2 |
PJT Partners
PJT
|
+$2.61M |
| 3 |
JPMorgan Chase
JPM
|
+$880K |
| 4 |
Crocs
CROX
|
+$847K |
| 5 |
Pfizer
PFE
|
+$580K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.94% |
| 2 | Financials | 4.94% |
| 3 | Consumer Discretionary | 1.52% |
| 4 | Communication Services | 0.52% |
| 5 | Healthcare | 0.49% |
Similar funds
CL
IHAM
NSCM
DDPIC
ACG
NSUP
ACM
TP
Klingman & Associates's Q2 2021 Portfolio in Review
As of Q2 2021, Klingman & Associates held 181 positions worth $1.04B, up 7.8% from $967M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Klingman & Associates's Q2 2021 filing shows 9 new, 59 increased, 50 reduced and 18 closed positions. Its largest new stake was Dimensional US Targeted Value ETF: 64,917 shares worth $2.91M. The largest sale was Datadog, an estimated $5.39M.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Discretionary.
- Klingman & Associates's largest Q2 2021 buy was Dimensional US Targeted Value ETF: 64,917 shares worth $2.91M.
- Klingman & Associates added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $5.58M increase.
- Klingman & Associates's biggest Q2 2021 reduction was Datadog, cutting an estimated $5.39M.
- Klingman & Associates fully exited NRC Health Common Stock in Q2 2021, selling an estimated $328K.
- Klingman & Associates's ten largest holdings make up 57% of its $1.04B portfolio in Q2 2021.
- Klingman & Associates opened 9 new positions and closed 18 in Q2 2021.
- Klingman & Associates's portfolio value rose 7.8% quarter-over-quarter to $1.04B.
Based on Klingman & Associates's 13F filing for Q2 2021, filed 27 Jul 2021.